| Name | endothelium and lymphocyte associated ASCH domain 1 |
| Description | Involved in regulation of interleukin-6 production. Located in mitochondrion. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Endothelial‐overexpressed lipopolysaccharide‐associated factor 1 (EOLA1) is an intracellular protein that plays a multifaceted role in vascular endothelial cell homeostasis. It is rapidly induced by lipopolysaccharide (LPS) stimulation and, through its physical interaction with metallothionein 2A (MT2A), acts as a negative regulator of inflammatory responses by suppressing the production of pro‐inflammatory mediators such as interleukin‑6 and vascular cell adhesion molecule‑1, and by protecting cells from LPS‐induced apoptosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Moreover, EOLA1 influences endothelial cell proliferation as its overexpression enhances cell growth whereas its inhibition slows proliferation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Molecular cloning studies have revealed that EOLA1 is encoded by a 1404‐bp transcript producing a 158–amino acid protein that localizes to both the nucleus and the cytoplasmic matrix, consistent with its function as a signal transduction factor."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "7"}]}, {"type": "t", "text": " Its role also appears pertinent in pathological settings such as diabetic foot ulcers and liver graft rejection, in which reduced EOLA1 expression correlates with exacerbated inflammatory responses and tissue injury."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Finally, structural analysis indicates that EOLA1 adopts a β‑barrel fold similar to an activating signal cointegrator‑1 homology (ASCH) domain, suggesting a conserved mechanism for intermolecular interactions that may underlie its regulatory functions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": " Collectively, these studies support a model in which EOLA1 serves as a critical intracellular modulator that fine‑tunes inflammatory signaling and promotes endothelial cell survival and proliferation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yueming Liu, Hairong Liu, Wenhai Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EOLA1 protects lipopolysaccharide induced IL-6 production and apoptosis by regulation of MT2A in human umbilical vein endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-014-2110-7"}], "href": "https://doi.org/10.1007/s11010-014-2110-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24916366"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24916366"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Weiling Leng, Xiaotian Lei, Hao Meng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EOLA1 Inhibits Lipopolysaccharide-Induced Vascular Cell Adhesion Molecule-1 Expression by Association with MT2A in ECV304 Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Inflam (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2015/301562"}], "href": "https://doi.org/10.1155/2015/301562"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26881174"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26881174"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zi-wen Liang, Zong-cheng Yang, Jian Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[The effect of inhibiting EOLA1 expression in ECV304 cells]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2007)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17557240"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17557240"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yu Chen, Zi-wen Liang, Yue-ming Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Establishment of human endothelial-overexpressed lipopolysaccharide-associated factor 1 compelling expression model and its effects on the proliferation of ECV304 cells]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Shao Shang Za Zhi (2005)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16185414"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16185414"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ziwen Liang, Zongcheng Yang "}, {"type": "b", "children": [{"type": "t", "text": "Identification and characterization of a novel gene EOLA1 stimulating ECV304 cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2004.10.124"}], "href": "https://doi.org/10.1016/j.bbrc.2004.10.124"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15541360"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15541360"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Zi-wen Liang, Zong-cheng Yang, Yue-ming Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Identification and characterization of a novel gene EOLA1 stimulating ECV304 cell proliferation]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2005)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16215939"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16215939"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Min Luo, Zi-Wen Liang, Zong-Cheng Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Subcellular localization of human endothelial-overexpressed lipopolysaccharide-associated factor 1 protein]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Shao Shang Za Zhi (2010)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21223654"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21223654"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Mingxia Wu, Weiling Leng, Hang Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Reduced Expression of EOLA1 May Be Related to Refractory Diabetic Foot Ulcer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mediators Inflamm (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2019/6705424"}], "href": "https://doi.org/10.1155/2019/6705424"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31007603"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31007603"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "C F Ran, K Dou, Z Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Changes in the expression of endothelial-overexpressed lipopolysaccharide-associated factor 1 in grafts during acute rejection following liver transplantation in rats."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Int Med Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/147323000803600309"}], "href": "https://doi.org/10.1177/147323000803600309"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18534126"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18534126"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Minju Kim, Sang Ho Park, Joon Sung Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal Structure of Human EOLA1 Implies Its Possibility of RNA Binding."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Molecules (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/molecules24193529"}], "href": "https://doi.org/10.3390/molecules24193529"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31569543"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31569543"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yue-Ming Liu, Hai-Rong Liu, Zhen Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Preparation of polyclonal antibody of human endothelial-overexpressed lipopolysaccharide-associated factor 1]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Shao Shang Za Zhi (2010)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21223656"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21223656"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Zhen Cai, Zi-wen Liang, Xiang-dong Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Purification of human endothelial overexpressed lipopolysaccharide-associated factor 1 protein]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Shao Shang Za Zhi (2005)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16383041"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16383041"}]}]}]}
|
| NCBI Gene ID | 91966 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
EOLA1 has 1,129 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 13 datasets.
Click the + buttons to view associations for EOLA1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of EOLA1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of EOLA1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with EOLA1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of EOLA1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving EOLA1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of EOLA1 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of EOLA1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of EOLA1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of EOLA1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of EOLA1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of EOLA1 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of EOLA1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of EOLA1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |